Daniel L. Reuvers Net Worth

The estimated Net Worth of Daniel L. Reuvers is at least $5.18 million dollars as of 27 February 2024. Mr Reuvers owns over 6,085 units of Tactile Systems Technology Inc stock worth over $3,130,055 and over the last 11 years he sold TCMD stock worth over $1,218,229. In addition, he makes $836,216 as Pres et CEO & Director at Tactile Systems Technology Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Reuvers TCMD stock SEC Form 4 insiders trading

Mr has made over 16 trades of the Tactile Systems Technology Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 6,085 units of TCMD stock worth $94,439 on 27 February 2024.

The largest trade he's ever made was exercising 23,330 units of Tactile Systems Technology Inc stock on 11 May 2020 worth over $862,510. On average, Mr trades about 1,466 units every 81 days since 2013. As of 27 February 2024 he still owns at least 238,027 units of Tactile Systems Technology Inc stock.

You can see the complete history of Mr Reuvers stock trades at the bottom of the page.

Mr. Daniel L. Reuvers biography

Daniel L. Reuvers is the Pres, CEO & Director at Tactile Systems Technology Inc.

What is the salary of Mr Reuvers?

As the Pres et CEO & Director of Tactile Systems Technology Inc, the total compensation of Mr Reuvers at Tactile Systems Technology Inc is $836,216. There are 3 executives at Tactile Systems Technology Inc getting paid more, with Gerald R. Mattys having the highest compensation of $1,306,465.

How old is Mr Reuvers?

Mr Reuvers is 58, he's been the Pres et CEO & Director of Tactile Systems Technology Inc since . There are 8 older and 6 younger executives at Tactile Systems Technology Inc. The oldest executive at Tactile Systems Technology Inc is Peter Soderberg, 73, who is the Independent Chairman of the Board.

What's Mr Reuvers's mailing address?

Daniel's mailing address filed with the SEC is 3701 WAYZATA BLVD., SUITE 300, MINNEAPOLIS, MN, 55416.

Insiders trading at Tactile Systems Technology Inc

Over the last 8 years, insiders at Tactile Systems Technology Inc have traded over $215,774,039 worth of Tactile Systems Technology Inc stock and bought 284,300 units worth $3,558,518 . The most active insiders traders include Zubeen Shroff, Partners V Lp Galen Partner... et Jordan Davis. On average, Tactile Systems Technology Inc executives and independent directors trade stock every 11 days with the average trade being worth of $402,508. The most recent stock trade was executed by Sherri Lee Ferstler on 12 August 2024, trading 1,550 units of TCMD stock currently worth $20,259.

What does Tactile Systems Technology Inc do?

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.

Complete history of Mr Reuvers stock trades at Integra Lifesciences Corp et Tactile Systems Technology Inc

Tactile Systems Technology Inc executives and stock owners

Tactile Systems Technology Inc executives and other stock owners filed with the SEC include:

• Gerald R. Mattys,
  Consultant
• Bryan Rishe,
  Senior Vice President of Sales
• Brent Moen,
  Chief Financial Officer
• Daniel L. Reuvers,
  Pres, CEO & Director
• Bryan F. Rishe,
  Sr. VP of Sales
• Brent A. Moen,
  Chief Financial Officer
• Eric C. Pauls,
  Sr. VP of Sales
• Kristie T. Burns,
  Sr. VP of Marketing & Clinical Affairs
• Peter Soderberg,
  Independent Chairman of the Board
• Richard Nigon,
  Independent Director
• William Burke,
  Independent Director
• Kevin Roche,
  Independent Director
• Cheryl Pegus,
  Independent Director
• Raymond Huggenberger,
  Independent Director
• Mike Piccinino,
  IR Contact Officer
• Jay Stracke,
  Vice President of Reimbursement and Payer Relations
• Peter Schaubach,
  Chief Information Officer
• Daniel Reuvers,
  President, Chief Executive Officer, Director
• Janelle Strop,
  Chief Human Resource Officer
• Thomas F. O'Donnell Jr., M.D.,
  Chief Medical Officer & Member of Vascular Strategic Advisory Board
• Kristie Burns,
  Sr. VP of Marketing & Clinical Affairs
• Jerry Sauber,
  VP of Operations
• Eric Pauls,
  Sr. VP of Sales
• Darren J. Wennen,
  Sr. VP of Commercial Operations
• Thomas F. O'Donnell Jr.,
  Chief Medical Officer
• Juleen F. Krings,
  Chief HR Officer
• Sunday J. Hoy,
  VP & Compliance Officer
• Mark W. Aldridge,
  VP of Operations
• Valerie L. Asbury,
  Director
• Robert J. Folkes,
  Chief Operating Officer
• Zubeen Shroff,
  Director
• Mary E. Anderson,
  Vice President, Reimbursement
• Venture Partners Iii, Llcra...,
  
• Jordan Davis,
  Director
• Partners V Lp Galen Partner...,
  
• Lynn Larson Blake,
  Chief Financial Officer
• Gerald R. Mattys,
  Chief Executive Officer
• Stephen I Shapiro,
  Director
• Venture Partners Iii, Llcra...,
  
• Maggie Thompson,
  VP Payer Rltns & Govt Affr
• Deepti Jain,
  Director
• Boyd Vindell Washington,
  Director
• Kristie Burns,
  Sr. VP Mktg & Clinical Affairs
• Eric Pauls,
  Senior VP, Sales
• David Brent Shafer,
  Director
• Carmen B Volkart,
  Director
• Elaine M. Birkemeyer,
  Chief Financial Officer
• Sherri Lee Ferstler,
  Senior VP, Sales
• Sheri Louise Dodd,
  Chief Executive Officer